Brief: Theralase® Demonstrates Proof-Of-Concept For Canadian-Made COVID-19 Vaccine
07/02/2022 12:37
Feb 7 (Reuters) - Theralase Technologies Inc TLT.V :
* THERALASE® DEMONSTRATES PROOF-OF-CONCEPT FOR CANADIAN-MADE
COVID-19 VACCINE
Source text for Eikon: ID:nGNX4x3Jc2
Further company coverage: TLT.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theralase Technologies
See all newsBrief: Theralase Releases FY2022 Audited Financial Statements
Brief: Theralase Commences $CAN 2.5 M Follow-On Private Placement Equity Financing
Brief: Theralase Closes $2.5 Mln Private Placement Equity Financing
Brief: Theralase Phase IB NMIBC Clinical Study Published
Brief: Theralase® Demonstrates Proof-Of-Concept For Canadian-Made COVID-19 Vaccine